188 related articles for article (PubMed ID: 35660710)
1. Personalized management for unmet needs with food allergy.
Miura Y; Yanagida N; Sato S; Ebisawa M
Curr Opin Allergy Clin Immunol; 2022 Jun; 22(3):160-166. PubMed ID: 35660710
[TBL] [Abstract][Full Text] [Related]
2. Relationship between eliciting doses and the severity of allergic reactions to food.
Yanagida N; Sato S; Ebisawa M
Curr Opin Allergy Clin Immunol; 2023 Jun; 23(3):226-232. PubMed ID: 37185827
[TBL] [Abstract][Full Text] [Related]
3. New approach for food allergy management using low-dose oral food challenges and low-dose oral immunotherapies.
Yanagida N; Okada Y; Sato S; Ebisawa M
Allergol Int; 2016 Apr; 65(2):135-140. PubMed ID: 26774524
[TBL] [Abstract][Full Text] [Related]
4. Patient quality of life following induction of oral immunotherapy for food allergy.
Epstein Rigbi N; Katz Y; Goldberg MR; Levy MB; Nachshon L; Elizur A
Pediatr Allergy Immunol; 2016 May; 27(3):263-8. PubMed ID: 26681071
[TBL] [Abstract][Full Text] [Related]
5. Efficacy, Safety, and Quality of Life in a Multicenter, Randomized, Placebo-Controlled Trial of Low-Dose Peanut Oral Immunotherapy in Children with Peanut Allergy.
Blumchen K; Trendelenburg V; Ahrens F; Gruebl A; Hamelmann E; Hansen G; Heinzmann A; Nemat K; Holzhauser T; Roeder M; Rosenfeld L; Hartmann O; Niggemann B; Beyer K
J Allergy Clin Immunol Pract; 2019 Feb; 7(2):479-491.e10. PubMed ID: 30423449
[TBL] [Abstract][Full Text] [Related]
6. Allergen-specific oral immunotherapy for peanut allergy.
Nurmatov U; Venderbosch I; Devereux G; Simons FE; Sheikh A
Cochrane Database Syst Rev; 2012 Sep; (9):CD009014. PubMed ID: 22972130
[TBL] [Abstract][Full Text] [Related]
7. Oral immunotherapy for peanut allergy: The pro argument.
Chinthrajah RS; Cao S; Dunham T; Sampath V; Chandra S; Chen M; Sindher S; Nadeau K
World Allergy Organ J; 2020 Aug; 13(8):100455. PubMed ID: 33005286
[TBL] [Abstract][Full Text] [Related]
8. Oral Immunotherapy for Hazelnut Allergy: A Single-Center Retrospective Study on 100 Patients.
Moraly T; Pelletier de Chambure D; Verdun S; Preda C; Seynave M; Vilain AC; Chenivesse C; Delebarre-Sauvage C
J Allergy Clin Immunol Pract; 2020 Feb; 8(2):704-709.e4. PubMed ID: 31751759
[TBL] [Abstract][Full Text] [Related]
9. Weighing the benefits and risks of oral immunotherapy in clinical practice.
Anagnostou A
Allergy Asthma Proc; 2021 Mar; 42(2):118-123. PubMed ID: 33685555
[TBL] [Abstract][Full Text] [Related]
10. Combining Anti-IgE Monoclonal Antibodies and Oral Immunotherapy for the Treatment of Food Allergy.
Guilleminault L; Michelet M; Reber LL
Clin Rev Allergy Immunol; 2022 Feb; 62(1):216-231. PubMed ID: 34550555
[TBL] [Abstract][Full Text] [Related]
11. Oral Immunotherapy for Food Allergy.
Burbank AJ; Sood P; Vickery BP; Wood RA
Immunol Allergy Clin North Am; 2016 Feb; 36(1):55-69. PubMed ID: 26617227
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of baked egg oral immunotherapy in French children with hen's egg allergy.
Gruzelle V; Juchet A; Martin-Blondel A; Michelet M; Chabbert-Broue A; Didier A
Pediatr Allergy Immunol; 2021 Jul; 32(5):1022-1028. PubMed ID: 33349960
[TBL] [Abstract][Full Text] [Related]
13. Patient Characteristics and Risk Factors for Home Epinephrine-Treated Reactions During Oral Immunotherapy for Food Allergy.
Nachshon L; Schwartz N; Tsviban L; Levy MB; Goldberg MR; Epstein-Rigby N; Katz Y; Elizur A
J Allergy Clin Immunol Pract; 2021 Jan; 9(1):185-192.e3. PubMed ID: 32750430
[TBL] [Abstract][Full Text] [Related]
14. Omalizumab effectiveness in patients with a previously failed oral immunotherapy for severe milk allergy.
Badina L; Belluzzi B; Contorno S; Bossini B; Benelli E; Barbi E; Berti I
Immun Inflamm Dis; 2022 Jan; 10(1):117-120. PubMed ID: 34623772
[TBL] [Abstract][Full Text] [Related]
15. Food specific oral immunotherapy: a potential treatment for food allergy.
Burbank AJ; Burks W
Expert Rev Gastroenterol Hepatol; 2015; 9(9):1147-59. PubMed ID: 26145713
[TBL] [Abstract][Full Text] [Related]
16. Quality of Life of Food-Allergic Patients Before, During, and After Oral Immunotherapy.
Epstein-Rigbi N; Goldberg MR; Levy MB; Nachshon L; Elizur A
J Allergy Clin Immunol Pract; 2019 Feb; 7(2):429-436.e2. PubMed ID: 30129441
[TBL] [Abstract][Full Text] [Related]
17. Changes in patient quality of life during oral immunotherapy for food allergy.
Rigbi NE; Goldberg MR; Levy MB; Nachshon L; Golobov K; Elizur A
Allergy; 2017 Dec; 72(12):1883-1890. PubMed ID: 28542911
[TBL] [Abstract][Full Text] [Related]
18. An Approach to the Office-Based Practice of Food Oral Immunotherapy.
Wasserman RL; Factor J; Windom HH; Abrams EM; Begin P; Chan ES; Greenhawt M; Hare N; Mack DP; Mansfield L; Ben-Shoshan M; Stukus DR; Leek TV; Shaker M
J Allergy Clin Immunol Pract; 2021 May; 9(5):1826-1838.e8. PubMed ID: 33684637
[TBL] [Abstract][Full Text] [Related]
19. Clinical aspects of oral immunotherapy for the treatment of allergies.
Yanagida N; Sato S; Ebisawa M
Semin Immunol; 2017 Apr; 30():45-51. PubMed ID: 28780220
[TBL] [Abstract][Full Text] [Related]
20. Is oral immunotherapy the cure for food allergies?
Nowak-Wegrzyn A; Fiocchi A
Curr Opin Allergy Clin Immunol; 2010 Jun; 10(3):214-9. PubMed ID: 20431369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
